Factor V Leiden and prothrombin gene G20210A mutation in children with venous thromboembolism

Thrombosis and Haemostasis

Volumn 87, Issue 6, 2002, Pages 972-977

  Bonduel, Mariana ^a   Hepner, Mirta ^a   Sciuccati, Gabriela ^a   Pieroni, Graciela ^a   Feliú Torres, Aurora ^a   Mardaraz, Claudia ^a   Frontroth, Juan Pablo ^a  

^a HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

Author keywords

Children; Factor V Leiden; Prothrombin gene G20210A mutation; Prothrombotic abnormalities; Venous thromboembolism

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN; BLOOD CLOTTING FACTOR 5;

ADOLESCENT; ADULT; ARGENTINA; ARTICLE; BLOOD ANALYSIS; BLOOD CLOTTING PARAMETERS; BLOOD SAMPLING; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; INFANT; INHERITANCE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; POPULATION RISK; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; RISK MANAGEMENT; STATISTICAL SIGNIFICANCE; THROMBOEMBOLISM; VEIN THROMBOSIS; GENE FREQUENCY; GENETICS; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRESCHOOL CHILD; RISK;

ADOLESCENT; ARGENTINA; CHILD; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; FACTOR V; FEMALE; GENE FREQUENCY; HUMANS; INFANT; MALE; ODDS RATIO; POINT MUTATION; PROTHROMBIN; RISK FACTORS; THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 0036285919     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613120     Document Type: Article

References (48)

1. Venous thromboembolic complications (VTE) in children: First analysis of the Canadian Registry of VTE
2. Deep vein thrombosis in a 13-year-old boy with hereditary protein S deficiency and a review of the pediatric literature
3. Lupus anticoagulant in children with thrombosis
4. Childhood thrombosis
5. Antiphospholipid antibodies in pediatric systemic lupus erythematosus
6. Prevalence of factor V Leiden in children with thromboembolism
7. Disorders of hemostasis in childhood: Risk factors for venous thromboembolism
8. Factor V Leiden, protein C, and lipoprotein (a) in catheter-related thrombosis in childhood: A prospective study
9. Antiphospholipid antibodies and coagulation regulatory protein abnormalities in children with pulmonary emboli
10. Prothrombin G20210A gene mutation and further prothrombotic risk factors in childhood thrombophilia
11. Factor V G1691A and prothrombin G20210A in childhood spontaneous venous thrombosis - Evidence of an age-dependent thrombotic onset in carriers of factor V G1691A and prothrombin G20210A mutation
12. Prothrombotic abnormalities in children with venous thromboembolism
13. Congenital prothrombotic disorders: Presentation during infancy and childhood
14. Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors
15. Thromboembolism in newborns, infants and children
16. Mutation in blood coagulation factor V associated with resistance to activated protein C
17. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
18. Inherited defects of the protein C anticoagulant system in childhood thromboembolism
19. Factor V Leiden is not common in children with portal vein thrombosis
20. Activated protein C resistance and the factor V Leiden mutation in children with thrombosis
21. Inherited risk factors for thrombophilia in children with nephrotic syndrome
22. Prevalence of the factor V Leiden mutation in children and neonates with thromboembolic disease
23. Clinical manifestations in thrombotic children with factor V Leiden mutation
24. Abdominal venous thrombosis in neonates and infants: Role of prothrombotic risk factors - A multicentre case-control study
25. Electroimmuno assay
26. Familial protein S deficiency is associated with thrombosis
27. Criteria for the diagnosis of lupus anticoagulants: An update. On behalf of the Subcommittee on lupus anticoagulant/antiphospholipid antibody of the scientific and Standardization Committee of the ISTH
28. Laboratory diagnosis of lupus inhibitors: A comparison of the tissue thromboplastin inhibition procedure with a new platelet neutralization procedure
29. Evaluation of the anti-cardiolipin antibody test: Report of an international workshop held 4 April 1986
30. Antiphospholipid antibody syndrome
31. Multiplex ASA PCR for a simultaneous determination of factor V Leiden gene, G→A 20210 prothrombin gene and C→T 677 MTHFR gene mutations
32. Venous thromboembolic complications in children
33. Epidemiology of venous thromboembolic events
34. Risk factors for venous thrombosis: Prevalence, risk, and interaction
35. Genetic susceptibility to venous thrombosis
36. Inherited thrombophilia: Part 1
37. The population genetics of factor V Leiden (Arg506Gln)
38. Venous thrombosis due to poor anticoagulant response to activated Protein C: Leiden thrombophilia study
39. Anticoagulant protein C pathway defective in the majority of thrombophilic patients
40. Resistance to activated protein C as a basis for venous thrombosis
41. Geographic distribution of the 20210 G to A prothrombin variant
42. The risk of venous thromboembolism in family members with mutations in the genes of factor V or prothrombin or both
43. Activated protein C resistance as an additional risk factor for thrombosis in protein C deficient families
44. Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S
45. Factor V Leiden as an independent risk factor for thrombosis and antithrombin deficiency type II: Heparin binding site
46. Co-inheritance of the 20210A allele of the prothrombin gene increases the risk of thrombosis in subjects with familial thrombophilia
47. Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: Prevalence and risk assessment
48. Factor V Leiden mutation in the Argentinian population